Meeting Banner
Abstract #1634

A Prospective, Randomized, Blinded Study of MultiHance on 1.5T and 3.0T Strength Field: An Evaluation of Brain, Optic Nerve and Spinal Cord Protocols in Multiple Sclerosis Patients

Robert Zivadinov1, Sara Hussein1, Cheryl Kennedy1, Niels Bergsland1, Christina Brooks, Michael G. Dwyer1

1Buffalo Neuroimaging Analysis Center, Buffalo, NY, United States

This was prospective, randomized, cross-over, blinded study that included 86 RRMS patients who underwent brain, 53 spinal cord and 40 optic nerve MRI exams at both 1.5T and 3.0T. The same scanning protocol was applied at two scanner field strengths (1.5T and 3.0T) after administration of MultiHance 0.1 mmol/kg body weight (injection, 529 mg/mL) with 5 min delay between injection and scanning. The use of a high relaxivity contrast agent, such as MultiHance at 3.0T field strength increases the diagnostic benefit in detecting enhancing lesions when compared intra-individually to the application of the same agent at 1.5 T.

Abstract PDF

Keywords

activity addition administration agent agents although analyses application applied automated background benefit binary blinded body bottom brain brooks buffalo carried central classified conducted contrast cord cross delay detecting detection developed diagnostic diseases enhancing enlarging episode evaluate evaluated evaluation exam except experienced fact field fields halfway hours house hypothesized identified included individual individually influence injection interval intra investigate issues lesion lesions manner many maps nausea nerve nervous newly objective occurred optic patient patients post produced projectile prospective protocol protocols randomization randomized rank relapsing remitting reported represent safety scanner scanners scanning sclerosis semi significantly simple software space spinal strength strengths system thirteen tool trend tumors underwent visible volume volumetric vomiting wise